Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Swiss drug maker Roche posts flat 9-month sales
Yahoo/AP
Thursday, October 16, 2014 - 7:49am
tags:
Roche
Was Celgene's Crohn's Disease Drug Worth The Price?
Investors.com
Thursday, October 16, 2014 - 7:48am
tags:
Celgene, Crohn's Disease, GED-0301
AbbVie Board Recommends Holders Vote Against Shire Deal
Bloomberg
Thursday, October 16, 2014 - 7:47am
tags:
AbbVie, Shire, tax inversions, M&A
Roche, Boehringer Drugs Wins Approval for Lung Disease
Bloomberg
Wednesday, October 15, 2014 - 4:49pm
tags:
Roche, Boehringer Ingelheim, FDA, IPF, idiopathic pulmonary fibros, Esbriet, Ofev
Merck unit to pay $31 mln to settle fraud claims by U.S. states
Yahoo/Reuters
Wednesday, October 15, 2014 - 4:43pm
tags:
Merck, Medicaid, Medicaid fraud, whistleblower lawsuits, Organon
AbbVie, Shire Have Options Besides Each Other: Real M&A
Bloomberg
Wednesday, October 15, 2014 - 2:54pm
tags:
M&A, AbbVie, Shire, tax inversions, Allergan, Valeant Pharmaceuticals
Should Gilead Sciences, inc. Fear Incoming Competition?
Motley Fool
Wednesday, October 15, 2014 - 2:51pm
tags:
Gilead Sciences, hepatitis C, AbbVie, Bristol-Myers Squibb
GSK starts unloading older meds by region, with $3B portfolio up for grabs
Fierce Pharma
Wednesday, October 15, 2014 - 1:18pm
tags:
GSK, reorganization
Here’s Why iBio’s Shares Are Plummeting
Bidness Etc.
Wednesday, October 15, 2014 - 1:13pm
tags:
iBio, Mapp Biopharmaceutical, ebola virus
Orexigen pockets $100M in milestone cash for Contrave
Fierce Biotech
Wednesday, October 15, 2014 - 12:26pm
tags:
Orexigen, Contrave, Takeda
Medtronic reports positive CoreValve data
Mass Device
Wednesday, October 15, 2014 - 12:24pm
tags:
Medtronic, devices, CoreValve, aortic valve replacement
Supreme Court seems divided in patent dispute over best-selling multiple sclerosis drug
Yahoo/AP
Wednesday, October 15, 2014 - 12:23pm
tags:
Supreme Court, generics, multiple sclerosis, MS, Teva Pharmaceutical, Copaxone
What Does Closing the ‘Double Irish’ Tax Loophole Mean for Pharma?
WSJ Pharmalot
Wednesday, October 15, 2014 - 11:33am
tags:
Ireland, tax inversions
Can Amgen's marketing muscle vault its Humira biosim ahead of rivals?
Fierce Pharma Marketing
Wednesday, October 15, 2014 - 11:13am
tags:
Amgen, biosimilars, Humira, ABP 501, Novartis, Boehringer Ingelheim
Selecta banks $20M for trial work, inks a pact with Sanofi on diabetes
Fierce Biotech
Wednesday, October 15, 2014 - 9:24am
tags:
Sanofi, Selecta, vaccines
St.Jude Medical adjusted profit rises
Yahoo/Reuters
Wednesday, October 15, 2014 - 8:59am
tags:
St. Jude Medical, devices, earnings
FDA approves expanded label for Lymphoseek
Seeking Alpha
Wednesday, October 15, 2014 - 8:10am
tags:
FDA, Lymphoseek, Navidea Biopharmaceuticals
Shire says AbbVie should not renege on merger deal
Yahoo/Reuters
Wednesday, October 15, 2014 - 8:07am
tags:
Shire, AbbVie, M&A, tax inversions
Medgenics posts third-quarter loss of $3 million
Yahoo/AP
Wednesday, October 15, 2014 - 8:04am
tags:
Medgenics, earnings
Will an FDA Policy Shift on Fixed-Dose Drug Approvals Anger Pharma?
WSJ Pharmalot
Tuesday, October 14, 2014 - 9:26pm
tags:
drug approvals, FDA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.